AI Assistant
Blog
Pricing
Log In
Sign Up
P496 Successful dose de-escalation to adalimumab 40mg every three weeks in patients with Crohn's disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
